比较欧洲抗菌药物敏感性试验委员会和临床与实验室标准协会的肉汤微量稀释法，用于测试曲霉菌分离株的伊曲康唑、泊沙康唑和伏立康唑。
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.
机构信息
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA.
出版信息
J Clin Microbiol. 2011 Mar;49(3):1110-2. doi: 10.1128/JCM.02432-10. Epub 2011 Jan 5.
Abstract
We compared EUCAST and CLSI antifungal susceptibility testing methods for itraconazole, posaconazole, and voriconazole by testing 245 Aspergillus clinical isolates. The essential agreement (EA) between methods was excellent: 100% (itraconazole), 98.4% (posaconazole), and 99.6% (voriconazole) assessing EA at ±2 dilutions and 99.6% (itraconazole), 87.7% (posaconazole), and 96.3% (voriconazole) at ±1 dilution.
摘要
我们通过测试 245 株曲霉菌临床分离株，比较了 EUCAST 和 CLSI 的抗真菌药敏检测方法，用于检测伊曲康唑、泊沙康唑和伏立康唑。方法之间的基本一致率（EA）非常高：±2 倍稀释时，伊曲康唑为 100%（EA），泊沙康唑为 98.4%（EA），伏立康唑为 99.6%（EA）；±1 倍稀释时，伊曲康唑为 99.6%（EA），泊沙康唑为 87.7%（EA），伏立康唑为 96.3%（EA）。
相似文献
1
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.比较欧洲抗菌药物敏感性试验委员会和临床与实验室标准协会的肉汤微量稀释法，用于测试曲霉菌分离株的伊曲康唑、泊沙康唑和伏立康唑。
J Clin Microbiol. 2011 Mar;49(3):1110-2. doi: 10.1128/JCM.02432-10. Epub 2011 Jan 5.
2
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.CLSI 和 EUCAST 肉汤微量稀释法检测新型广谱抗真菌药物 E1210 对曲霉菌属的体外活性。
Antimicrob Agents Chemother. 2011 Nov;55(11):5155-8. doi: 10.1128/AAC.00570-11. Epub 2011 Aug 15.
3
Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.比较 Sensititre YeastOne 和 CLSI M38-A2 微量稀释法测定两性霉素 B、伊曲康唑、伏立康唑和泊沙康唑对曲霉属的活性。
J Clin Microbiol. 2018 Sep 25;56(10). doi: 10.1128/JCM.00780-18. Print 2018 Oct.
4
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.泊沙康唑、雷夫康唑和伏立康唑与伊曲康唑及两性霉素B相比，对239株曲霉属及其他丝状真菌临床分离株的抗真菌活性：2000年SENTRY抗菌监测项目报告
Antimicrob Agents Chemother. 2002 Apr;46(4):1032-7. doi: 10.1128/AAC.46.4.1032-1037.2002.
5
In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.曲霉属菌种的体外药敏试验：用于测定伏立康唑和伊曲康唑最低抑菌浓度（MIC）的Etest法与参考微量稀释法的比较
J Clin Microbiol. 2003 Mar;41(3):1126-9. doi: 10.1128/JCM.41.3.1126-1129.2003.
6
Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole.纸片扩散法、E试验和肉汤微量稀释法在测定曲霉属对两性霉素B、伊曲康唑和伏立康唑敏感性中的比较
J Chemother. 2008 Feb;20(1):87-92. doi: 10.1179/joc.2008.20.1.87.
7
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).CLSI 肉汤微量稀释法（M38-A2 文件）中三唑类药物和六种曲霉菌属的野生型 MIC 分布和流行病学折点值。
J Clin Microbiol. 2010 Sep;48(9):3251-7. doi: 10.1128/JCM.00536-10. Epub 2010 Jun 30.
8
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.欧盟CAST和CLSI M27 - A2肉汤微量稀释法检测念珠菌属对氟康唑、伊曲康唑、泊沙康唑和伏立康唑药敏的国际多中心比较
J Clin Microbiol. 2005 Aug;43(8):3884-9. doi: 10.1128/JCM.43.8.3884-3889.2005.
9
Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.欧盟CAST-AFST肉汤稀释法与CLSI参考肉汤稀释法（M38-A）用于泊沙康唑和伏立康唑对曲霉属真菌药敏试验的比较
Clin Microbiol Infect. 2006 Sep;12(9):901-4. doi: 10.1111/j.1469-0691.2006.01419.x.
10
Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.伊曲康唑、氟康唑和伏立康唑对皮肤癣菌体外药敏试验的E试验、纸片扩散法和改良的CLSI肉汤微量稀释法（M 38 - A）比较
Med Mycol. 2008 Mar;46(2):119-23. doi: 10.1080/13693780701670491.
引用本文的文献
1
High-Throughput Monitoring of Pathogenic Fungal Growth Using Whole Slide Imaging for Rapid Antifungal Susceptibility Assessment.使用全玻片成像进行高通量监测致病性真菌生长以进行快速抗真菌药敏评估
Anal Lett. 2024;57(15):2412-2425. doi: 10.1080/00032719.2023.2297301. Epub 2023 Dec 29.
2
In vitro susceptibility testing for black grain eumycetoma causative agents.体外药敏试验对黑色颗粒外瓶霉病致病因子。
Trans R Soc Trop Med Hyg. 2021 Apr 14;115(4):343-354. doi: 10.1093/trstmh/traa184.
3
Fulminant Tracheobronchial Aspergillosis in an Apparently Healthy Adult.一名看似健康的成年人发生暴发性气管支气管曲霉病。
Intern Med. 2020;59(10):1295-1298. doi: 10.2169/internalmedicine.3857-19. Epub 2020 May 15.
4
Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside.应对抗真菌药物耐药性的出现：来自实验室和临床的观点。
Future Microbiol. 2018 Aug;13(10):1175-1191. doi: 10.2217/fmb-2018-0059. Epub 2018 Aug 16.
5
Species and Antifungals Susceptibility in Clinical Setting in the North of Portugal: Cryptic Species and Emerging Azoles Resistance in .葡萄牙北部临床环境中的菌种及抗真菌药敏情况：隐匿菌种与新型唑类耐药性研究
Front Microbiol. 2018 Jul 23;9:1656. doi: 10.3389/fmicb.2018.01656. eCollection 2018.
6
Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.欧盟CAST和CLSI肉汤微量稀释法检测艾沙康唑、泊沙康唑和两性霉素B对分子鉴定的毛霉目菌种的比较。
Antimicrob Agents Chemother. 2015 Dec;59(12):7882-7. doi: 10.1128/AAC.02107-15. Epub 2015 Oct 5.
7
Comparative analysis of quinolone resistance in clinical isolates of Klebsiella pneumoniae and Escherichia coli from Chinese children and adults.中国儿童和成人肺炎克雷伯菌及大肠杆菌临床分离株喹诺酮耐药性的比较分析
Biomed Res Int. 2015;2015:168292. doi: 10.1155/2015/168292. Epub 2015 Feb 10.
8
EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.欧盟CAST对曲霉中异曲康唑敏感性的检测：使用分生孢子计数与光密度进行接种物标准化的结果比较。
Antimicrob Agents Chemother. 2014 Nov;58(11):6432-6. doi: 10.1128/AAC.03779-14. Epub 2014 Aug 18.
9
Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.巴西的隐匿性和罕见曲霉菌种：临床样本中的流行情况及对三唑类药物的体外敏感性
J Clin Microbiol. 2014 Oct;52(10):3633-40. doi: 10.1128/JCM.01582-14. Epub 2014 Jul 30.
10
Antifungal drug discovery: the process and outcomes.抗真菌药物的发现：过程与成果。
Future Microbiol. 2014;9(6):791-805. doi: 10.2217/fmb.14.32.
本文引用的文献
1
Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology.根据欧洲抗菌药物敏感性试验委员会（EUCAST）方法对曲霉属进行的抗真菌药敏试验。
Med Mycol. 2006 Sep 1;44(Supplement_1):S319-S325. doi: 10.1080/13693780600779401.
2
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values.比较肉汤微量稀释（BMD）法和 24 小时 CLSI BMD 法，以流行病学折点值检测氟康唑、泊沙康唑和伏立康唑对念珠菌属的敏感性。
J Clin Microbiol. 2011 Mar;49(3):845-50. doi: 10.1128/JCM.02441-10. Epub 2011 Jan 12.
3
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles.利用流行病学截断值研究 9 年来 Aspergillus 属对三唑类药物敏感性的变化趋势。
J Clin Microbiol. 2011 Feb;49(2):586-90. doi: 10.1128/JCM.02136-10. Epub 2010 Dec 1.
4
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).CLSI 肉汤微量稀释法（M38-A2 文件）中三唑类药物和六种曲霉菌属的野生型 MIC 分布和流行病学折点值。
J Clin Microbiol. 2010 Sep;48(9):3251-7. doi: 10.1128/JCM.00536-10. Epub 2010 Jun 30.
5
In vitro susceptibility testing in fungi: a global perspective on a variety of methods.体外抗真菌药敏试验：各种方法的全球视角。
Mycoses. 2010 Jan;53(1):1-11. doi: 10.1111/j.1439-0507.2009.01813.x.
6
Azole-resistance in Aspergillus: proposed nomenclature and breakpoints.曲霉属唑类耐药：建议命名法和折点。
Drug Resist Updat. 2009 Dec;12(6):141-7. doi: 10.1016/j.drup.2009.09.002. Epub 2009 Oct 29.
7
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.临床分离曲霉菌属对安尼鲁单抗、卡泊芬净和米卡芬净的体外药敏性：CLSI M38-A2 肉汤微量稀释法头对头比较。
J Clin Microbiol. 2009 Oct;47(10):3323-5. doi: 10.1128/JCM.01155-09. Epub 2009 Aug 26.
8
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.根据临床和实验室标准协会的肉汤微量稀释方法，确定了烟曲霉野生型 MIC 分布和三种三唑类药物的流行病学截断值。
J Clin Microbiol. 2009 Oct;47(10):3142-6. doi: 10.1128/JCM.00940-09. Epub 2009 Aug 19.
9
Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.从参加移植相关感染监测网络的患者中分离出的烟曲霉分离株的敏感性模式。
J Clin Microbiol. 2009 Oct;47(10):3271-5. doi: 10.1128/JCM.00854-09. Epub 2009 Aug 19.
10
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.烟曲霉中唑类耐药与治疗失败相关的频率及演变
Emerg Infect Dis. 2009 Jul;15(7):1068-76. doi: 10.3201/eid1507.090043.
Zotero 插件